Acticor Biotech R&D and Labs

Acticor Biotech is a biopharmaceutical company developing an innovative drug for the treatment in the acute phase of ischemic stroke.


Investors

Total Funding: $33 202 489
Headquarters: Paris, Ile-de-France, France
Funding Status: Early Stage Venture
Estimated Revenue: $1M to $10M
Last Funding Type: Series B
Last Funding Date: 2019-11-06
Founded Date: 2010-01-01